These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37972825)
1. Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection. Keller MB; Tian X; Jang MK; Meda R; Charya A; Ozisik D; Berry GJ; Marboe CC; Kong H; Ponor IL; Aryal S; Orens JB; Shah PD; Nathan SD; Agbor-Enoh S J Heart Lung Transplant; 2024 Apr; 43(4):563-570. PubMed ID: 37972825 [TBL] [Abstract][Full Text] [Related]
2. Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial. Keller MB; Tian X; Jang MK; Meda R; Charya A; Berry GJ; Marboe CC; Kong H; Ponor IL; Aryal S; Orens JB; Shah PD; Nathan SD; Agbor-Enoh S Am J Respir Crit Care Med; 2024 May; 209(10):1238-1245. PubMed ID: 38190701 [No Abstract] [Full Text] [Related]
3. Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients. Ju C; Xu X; Zhang J; Chen A; Lian Q; Liu F; Liu H; Cai Y; Zou Y; Yang Y; Zhou Y; He J BMC Pulm Med; 2023 Jan; 23(1):37. PubMed ID: 36703125 [TBL] [Abstract][Full Text] [Related]
4. Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant. Rosenheck JP; Ross DJ; Botros M; Wong A; Sternberg J; Chen YA; Liang N; Baer A; Ahmed E; Swenerton R; Zimmermann BG; Fehringer G; Demko ZP; Olymbios M; Billings PR; Keller BC Transplant Direct; 2022 Apr; 8(4):e1317. PubMed ID: 35372675 [TBL] [Abstract][Full Text] [Related]
5. Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease. Keller MB; Newman D; Alnababteh M; Ponor L; Shah P; Mathew J; Kong H; Andargie T; Park W; Charya A; Luikart H; Aryal S; Nathan SD; Orens JB; Khush KK; Jang M; Agbor-Enoh S J Heart Lung Transplant; 2024 Sep; 43(9):1374-1382. PubMed ID: 38705500 [TBL] [Abstract][Full Text] [Related]
7. Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation. Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Huynh RH; Saggar R; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA Am J Transplant; 2017 May; 17(5):1294-1303. PubMed ID: 27676455 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study. Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940 [TBL] [Abstract][Full Text] [Related]
9. Pathologist interrater reliability and clinical implications of elevated donor-derived cell-free DNA beyond heart transplant rejection, on behalf of the GRAfT investigators. Mehta A; Goldberg J; Bagchi P; Marboe C; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Cochrane A; Tchoukina IF; Kong H; Lohmar BJ; Mcnair E; Valantine HA; Agbor-Enoh S; Berry GJ; Shah P J Heart Lung Transplant; 2024 Oct; ():. PubMed ID: 39424014 [TBL] [Abstract][Full Text] [Related]
10. Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation. Khush KK; De Vlaminck I; Luikart H; Ross DJ; Nicolls MR ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33532456 [TBL] [Abstract][Full Text] [Related]
11. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection. Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104 [TBL] [Abstract][Full Text] [Related]
12. Progress in Noninvasive Surveillance for Acute Rejection in Pediatric Heart Transplant Recipients: A Real-World Analysis of Donor-Derived Cell-Free DNA-Based Surveillance Protocol. Akabas L; Bravo SA; Zhang Y; Simonelli A; Zuckerman WA; Richmond ME; Lytrivi ID Clin Transplant; 2024 Oct; 38(10):e15481. PubMed ID: 39412485 [TBL] [Abstract][Full Text] [Related]
13. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care. Keller M; Sun J; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S J Heart Lung Transplant; 2022 Apr; 41(4):458-466. PubMed ID: 35063338 [TBL] [Abstract][Full Text] [Related]
14. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation. Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559 [TBL] [Abstract][Full Text] [Related]
15. Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study. Ranch D; Fei M; Kincade E; Piburn K; Hitchman K; Klein K Pediatr Transplant; 2024 Feb; 28(1):e14582. PubMed ID: 37550268 [TBL] [Abstract][Full Text] [Related]
16. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT). DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620 [TBL] [Abstract][Full Text] [Related]
17. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants. Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125 [TBL] [Abstract][Full Text] [Related]
18. The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation. Shino MY; Weigt SS; Li N; Palchevskiy V; Derhovanessian A; Saggar R; Sayah DM; Huynh RH; Gregson AL; Fishbein MC; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA PLoS One; 2017; 12(7):e0180281. PubMed ID: 28686641 [TBL] [Abstract][Full Text] [Related]
19. Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators. Shah P; Agbor-Enoh S; Lee S; Andargie TE; Sinha SS; Kong H; Henry L; Park W; McNair E; Tchoukina I; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Marboe C; Berry GJ; Valantine HA; Circ Heart Fail; 2024 Apr; 17(4):e011160. PubMed ID: 38375637 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study. Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C Front Immunol; 2020; 11():342. PubMed ID: 32184785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]